US Stock MarketDetailed Quotes

DRTSW ALPHA TAU MEDICAL LTD C/WTS 07/03/2027 (TO PUR COM)

Watchlist
  • 0.2400
  • +0.0413+20.79%
Close Aug 23 16:00 ET
0Market Cap0.00P/E (TTM)

ALPHA TAU MEDICAL LTD C/WTS 07/03/2027 (TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
10.85%9.05M
-2.55%8.42M
11.03%35.68M
24.52%9.94M
21.30%8.93M
1.95%8.17M
-1.56%8.64M
133.04%32.14M
102.51%7.99M
102.48%7.36M
Selling and administrative expenses
-1.13%2.19M
-15.48%1.98M
-17.70%9.26M
-5.83%2.45M
-11.02%2.25M
-13.69%2.21M
-34.07%2.34M
379.98%11.25M
264.85%2.61M
320.43%2.53M
-Selling and marketing expense
15.38%600K
33.25%533K
97.54%1.92M
13.85%452K
122.58%552K
329.75%520K
92.31%400K
102.07%974K
215.08%397K
143.14%248K
-General and administrative expense
-6.20%1.59M
-25.54%1.44M
-28.62%7.33M
-9.38%2M
-25.54%1.7M
-30.70%1.69M
-41.94%1.94M
451.96%10.27M
275.51%2.21M
356.60%2.28M
Research and development costs
15.30%6.87M
2.25%6.45M
26.49%26.42M
39.22%7.49M
38.24%6.67M
9.31%5.96M
20.46%6.31M
82.49%20.89M
66.62%5.38M
59.20%4.83M
Operating profit
-10.85%-9.05M
2.55%-8.42M
-11.03%-35.68M
-24.52%-9.94M
-21.30%-8.93M
-1.95%-8.17M
1.56%-8.64M
-133.04%-32.14M
-102.51%-7.99M
-102.48%-7.36M
Net non-operating interest income expense
29.20%1.87M
-7.11%444K
166.59%4.72M
-90.42%763K
-57.21%2.03M
-75.99%1.45M
102.82%478K
807.18%1.77M
-42.34%7.97M
506.16%4.74M
Non-operating interest income
----
----
169.83%4.83M
----
----
----
----
748.34%1.79M
----
----
Non-operating interest expense
----
----
--75K
----
----
----
----
--0
----
----
Total other finance cost
-6.54%457K
7.11%-444K
85.71%39K
164.63%3.99M
16.44%-3.96M
108.12%489K
-102.82%-478K
31.25%21K
54.60%-6.18M
-506.16%-4.74M
Other net income (expense)
154.01%1.82M
75.31%-3.38M
Gain on sale of security
----
----
154.01%1.82M
----
----
----
----
75.31%-3.38M
----
----
Income before tax
15.01%-7.37M
2.28%-7.98M
13.64%-29.14M
-116.83%-7.36M
-89.40%-4.95M
-334.87%-8.67M
68.28%-8.17M
-23.76%-33.74M
10.59%-3.39M
45.56%-2.61M
Income tax
-88.46%3K
-95.24%1K
-20.00%16K
166.67%8K
-533.33%-39K
333.33%26K
950.00%21K
185.71%20K
121.43%3K
280.00%9K
Net income
15.23%-7.37M
2.52%-7.98M
13.64%-29.16M
-116.87%-7.37M
-87.27%-4.91M
-334.87%-8.69M
68.20%-8.19M
-23.80%-33.76M
10.18%-3.4M
45.32%-2.62M
Net income continuous Operations
15.23%-7.37M
2.52%-7.98M
13.64%-29.16M
-116.87%-7.37M
-87.27%-4.91M
-334.87%-8.69M
68.20%-8.19M
-23.80%-33.76M
10.18%-3.4M
45.32%-2.62M
Minority interest income
Net income attributable to the parent company
15.23%-7.37M
2.52%-7.98M
13.64%-29.16M
-116.87%-7.37M
-87.27%-4.91M
-334.87%-8.69M
68.20%-8.19M
-23.80%-33.76M
10.18%-3.4M
45.32%-2.62M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
15.23%-7.37M
2.52%-7.98M
13.64%-29.16M
-116.87%-7.37M
-87.27%-4.91M
-334.87%-8.69M
68.20%-8.19M
-23.80%-33.76M
10.18%-3.4M
45.32%-2.62M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 10.85%9.05M-2.55%8.42M11.03%35.68M24.52%9.94M21.30%8.93M1.95%8.17M-1.56%8.64M133.04%32.14M102.51%7.99M102.48%7.36M
Selling and administrative expenses -1.13%2.19M-15.48%1.98M-17.70%9.26M-5.83%2.45M-11.02%2.25M-13.69%2.21M-34.07%2.34M379.98%11.25M264.85%2.61M320.43%2.53M
-Selling and marketing expense 15.38%600K33.25%533K97.54%1.92M13.85%452K122.58%552K329.75%520K92.31%400K102.07%974K215.08%397K143.14%248K
-General and administrative expense -6.20%1.59M-25.54%1.44M-28.62%7.33M-9.38%2M-25.54%1.7M-30.70%1.69M-41.94%1.94M451.96%10.27M275.51%2.21M356.60%2.28M
Research and development costs 15.30%6.87M2.25%6.45M26.49%26.42M39.22%7.49M38.24%6.67M9.31%5.96M20.46%6.31M82.49%20.89M66.62%5.38M59.20%4.83M
Operating profit -10.85%-9.05M2.55%-8.42M-11.03%-35.68M-24.52%-9.94M-21.30%-8.93M-1.95%-8.17M1.56%-8.64M-133.04%-32.14M-102.51%-7.99M-102.48%-7.36M
Net non-operating interest income expense 29.20%1.87M-7.11%444K166.59%4.72M-90.42%763K-57.21%2.03M-75.99%1.45M102.82%478K807.18%1.77M-42.34%7.97M506.16%4.74M
Non-operating interest income --------169.83%4.83M----------------748.34%1.79M--------
Non-operating interest expense ----------75K------------------0--------
Total other finance cost -6.54%457K7.11%-444K85.71%39K164.63%3.99M16.44%-3.96M108.12%489K-102.82%-478K31.25%21K54.60%-6.18M-506.16%-4.74M
Other net income (expense) 154.01%1.82M75.31%-3.38M
Gain on sale of security --------154.01%1.82M----------------75.31%-3.38M--------
Income before tax 15.01%-7.37M2.28%-7.98M13.64%-29.14M-116.83%-7.36M-89.40%-4.95M-334.87%-8.67M68.28%-8.17M-23.76%-33.74M10.59%-3.39M45.56%-2.61M
Income tax -88.46%3K-95.24%1K-20.00%16K166.67%8K-533.33%-39K333.33%26K950.00%21K185.71%20K121.43%3K280.00%9K
Net income 15.23%-7.37M2.52%-7.98M13.64%-29.16M-116.87%-7.37M-87.27%-4.91M-334.87%-8.69M68.20%-8.19M-23.80%-33.76M10.18%-3.4M45.32%-2.62M
Net income continuous Operations 15.23%-7.37M2.52%-7.98M13.64%-29.16M-116.87%-7.37M-87.27%-4.91M-334.87%-8.69M68.20%-8.19M-23.80%-33.76M10.18%-3.4M45.32%-2.62M
Minority interest income
Net income attributable to the parent company 15.23%-7.37M2.52%-7.98M13.64%-29.16M-116.87%-7.37M-87.27%-4.91M-334.87%-8.69M68.20%-8.19M-23.80%-33.76M10.18%-3.4M45.32%-2.62M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 15.23%-7.37M2.52%-7.98M13.64%-29.16M-116.87%-7.37M-87.27%-4.91M-334.87%-8.69M68.20%-8.19M-23.80%-33.76M10.18%-3.4M45.32%-2.62M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg